Quest Diagnostics (NYSE:DGX), a provider of diagnostic information services, announced on Wednesday that its board of directors declared a quarterly cash dividend of USD0.86 per share.
This amount is unchanged from the previous quarterly dividend.
The dividend is payable on 21 October 2026 to Quest Diagnostics' common stock shareholders of record on 6 October 2026.
Ridgetech reports financial results for fiscal year to March 2026
AMGEN announces Q3 2026 dividend
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases